Keywords: b-ms, discusses, two-year, orencia, trial, data, presentation
B-MS discusses two-year Orencia trial data
Article | 03 July 2006
In a presentation to the European League Against Rheumatism annual conference in Amsterdam, the Netherlands, US drug major Bristol-Myers Squibb ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
